Acne Vulgaris
📧 Sign up to get email alerts when something new happens for Acne Vulgaris.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2021-09-21FDA Approved: ISOTRETINOIN — Original Application (Upsher-Smith Laboratories, LLC)
FDA approves the original application for isotretinoin from Upsher-Smith Laboratories, LLC, for the treatment of acne vulgaris.
-
CLINICAL_TRIALS trial_result · 2021-09-20Clinical Trial Update: Dose Range Study of CD5789 in Acne Vulgaris [Phase 2]
Phase 2 dose range study of CD5789 in acne vulgaris has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2021-09-05Clinical Trial Update: Oral Baidi Quzhi Granule Combined With Ju Ying Cream for Acne Vulgaris [Phase 3]
Phase 3 clinical trial update for an oral Baidi Quzhi granule combined with Ju Ying cream in acne vulgaris.
-
FDA approval · 2021-08-19FDA Approved: WINLEVI — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
The FDA approved a supplemental application for WINLEVI (clascoterone) by Sun Pharmaceutical Industries, expanding its labeling for acne vul…
-
FDA approval · 2021-07-26FDA Approved: TWYNEO — Original Application (Galderma Laboratories, L.P.)
FDA approved TWYNEO, a fixed-dose combination of tretinoin and benzoyl peroxide, for acne vulgaris under Galderma Laboratories, L.P.'s origi…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2021-07-13Clinical Trial Update: Combined Treatment With CO2 Laser and Isotretinoin for Acne Scars [Phase 2]
Phase 2 trial evaluating combined CO2 laser and isotretinoin for acne vulgaris.
-
CLINICAL_TRIALS trial_result · 2021-05-04Clinical Trial Update: Bioequivalence Study of Clindamycin Phosphate Topical Lotion, 1% in Subjects With Acne Vulgaris [Phase 3]
Phase 3 bioequivalence study of clindamycin phosphate 1% topical lotion for acne vulgaris completed; results posted.
-
FDA approval · 2021-04-28FDA Approved: CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE — Original Application (Northstar Rx LLC)
The FDA approved a generic clindamycin phosphate and benzoyl peroxide topical combination for the treatment of acne vulgaris (ANDA 212433; O…
-
CLINICAL_TRIALS trial_result · 2021-04-23Clinical Trial Update: The Functional and Emotional Benefits of Replenix Power of Three With Resveratrol [Phase 4]
Phase 4 clinical trial update on Replenix Power of Three With Resveratrol for acne vulgaris; study is terminated.
-
FDA approval · 2021-04-12FDA Approved: ISOTRETINOIN — Original Application (Upsher-Smith Laboratories, LLC)
FDA approved Upsher-Smith Laboratories, LLC's isotretinoin under an Original Application (ANDA) for the treatment of severe acne.
-
CLINICAL_TRIALS trial_result · 2021-04-01Clinical Trial Update: A Phase 3, Vehicle-controlled Efficacy and Safety Study of IDP-123 Lotion in the Treatment of Acne Vulgaris (302) [Phase 3]
Phase 3, vehicle-controlled study of IDP-123 Lotion for acne vulgaris has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2021-04-01Clinical Trial Update: A Phase 3, Vehicle-controlled Efficacy and Safety Study of IDP-123 Lotion in the Treatment of Acne Vulgaris (301) [Phase 3]
Phase 3 clinical trial update for IDP-123 Lotion in acne vulgaris has completed with posted results.
-
FDA approval · 2021-03-31FDA Approved: ISOTRETINOIN — Original Application (Actavis Pharma, Inc.)
FDA approves Actavis's original ANDA for isotretinoin (generic) for the treatment of severe acne. This confirms a generic version of isotret…
-
FDA approval · 2021-03-18FDA Approved: CLINDAMYCIN PHOAPHATE TOPICAL SOLUTION USP, 1% — Supplemental Application (Encube Ethicals, Inc.)
FDA approves a supplemental application for CLINDAMYCIN PHOAPHATE TOPICAL SOLUTION USP, 1% (ANDA 209914) by Encube Ethicals, Inc.
-
CLINICAL_TRIALS trial_result · 2021-03-12Clinical Trial Update: Silymarin Cream Versus Salicylic Acid in Treatment of Acne Vulgaris [Phase 4]
Phase 4 trial comparing silymarin cream to salicylic acid for acne vulgaris.
-
FDA approval · 2021-03-11FDA Approved: CLINDAMYCIN PHOSPHATE — Original Application (Encube Ethicals, Inc.)
FDA approved Clindamycin Phosphate Gel USP, 1% (Original Application) from Encube Ethicals, Inc.
-
CLINICAL_TRIALS trial_result · 2021-02-23Clinical Trial Update: A Study Comparing Two Topicals in the Treatment of Acne Vulgaris [Phase 1]
Phase 1 trial comparing two topical treatments for acne vulgaris completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-02-17Clinical Trial Update: Efficacy and Safety of Fixed Combination Adapalene 0.1% / Benzoyl Peroxide 2.5% Gel in the Treatment of Acne Vulgaris [Phase 3]
Phase 3 trial update on fixed combination adapalene 0.1% / benzoyl peroxide 2.5% gel for acne vulgaris evaluating efficacy and safety.
-
CLINICAL_TRIALS trial_result · 2021-02-05Clinical Trial Update: A Study to Compare FCD105 Foam to Minocycline 3% Foam, Adapalene 0.3% Foam and Vehicle Foam. [Phase 2]
Phase 2 trial comparing FCD105 foam to minocycline, adapalene, and vehicle foams in acne vulgaris has completed.
-
CLINICAL_TRIALS trial_result · 2021-01-20Clinical Trial Update: A Study to Compare Clindamycin Phosphate and Benzoyl Peroxide Topical Gel 1.2%/2.5% to Acanya® Topical Gel in the Treatment of Acne Vulgaris [Phase 3]
Phase 3 study comparing clindamycin phosphate/benzoyl peroxide gel to Acanya gel for acne vulgaris has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-01-20Clinical Trial Update: Comparative Safety and Bioequivalence of Two Treatments in the Treatment of Acne Vulgaris [Phase 3]
Phase 3 trial comparing safety and bioequivalence of two acne vulgaris treatments; results posted after completion.
-
CLINICAL_TRIALS trial_result · 2021-01-05Clinical Trial Update: Bioequivalence Study of Two Treatments in the Treatment of Acne Vulgaris on the Face [Phase 3]
A Phase 3 bioequivalence study for two acne vulgaris treatments on the face has completed with results posted.
-
FDA approval · 2020-12-31FDA Approved: CLINDAMYCIN PHOSPHATE — Original Application (Padagis Israel Pharmaceuticals Ltd)
FDA approved a new original application for clindamycin phosphate, a generic formulation manufactured by Padagis Israel Pharmaceuticals Ltd.
-
CLINICAL_TRIALS trial_result · 2020-12-11Clinical Trial Update: Efficacy and Safety of CD5024 1% in Acne Vulgaris [Phase 2]
A Phase 2 trial assessing the efficacy and safety of CD5024 1% in acne vulgaris has completed with posted results.
-
FDA approval · 2020-12-09FDA Approved: ZENATANE — Supplemental Application (BluePoint Laboratories)
FDA approved a supplemental application for Zenatane (isotretinoin) submitted by BluePoint Laboratories.